Assignee
ALLOS THERAPEUTICS INC
US·7 granted patents·7 pending applications·77 citations·filing 1995–2014
Top patents by PatentIndex Score
14 records- 0188US6534501B2Allosteric inhibitors of pyruvate kinaseALLOS THERAPEUTICS INC·Filed 2001·Granted Mar 18, 2003·34 cites·12 claims
- 0271US5525630ATreatment for carbon monoxide poisoningALLOS THERAPEUTICS INC·Filed 1995·Granted Jun 11, 1996·36 cites·1 claims
- 0364US9187481B2(2S)-2-[[4-[(1R)-1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amin]pentanedioic acid for the treatment of inflammatory disordersALLOS THERAPEUTICS INC·Filed 2014·Granted Nov 17, 2015·1 cites·8 claims
- 0464US6894185B2Substituted chiral allosteric hemoglobin modifiersALLOS THERAPEUTICS INC·Filed 2002·Granted May 17, 2005·2 cites·5 claims
- 0563US8835433B2Optically pure diastereomers of 10-Propargyl-10-deazaaminopterin and methods of using same for the treatment of cancerALLOS THERAPEUTICS INC·Filed 2013·Granted Sep 16, 2014·1 cites·6 claims
- 0655US2009048262A1Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancerALLOS THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 0754US2007212302A1Preparation and Use of a Stable Formulation of Allosteric Effector CompoundsALLOS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 0851US9901578B2Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancerALLOS THERAPEUTICS INC·Filed 2013·Granted Feb 27, 2018·0 cites·3 claims
- 0944US7097825B2Methods and reagents to acquire MRI signals and imagesALLOS THERAPEUTICS INC·Filed 2002·Granted Aug 29, 2006·3 cites·11 claims
- 1041US2008039425A1Methods and Compositions to Reduce Tissue Irritation in Parenteral FormulationsALLOS THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1141US2007299136A1Crystalline and Amorphous Forms of Efaproxiral SodiumALLOS THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1239US2011190305A1Optically Pure Diastereomers of 10-Propargyl-10-Deazaaminopterin and Methods of Using SameALLOS THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 1338US2007259966A1Coadministration of Radiation, Efaproxiral Sodium, and Supplemental Oxygen for the Treatment of CancerALLOS THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1431US2010248249A1Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr LevelsALLOS THERAPEUTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ALLOS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →